G756-2320 Screening compound: 1-[3-({7-chloro-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl}methoxy)phenyl]-3-(2,3-dihydro-1,4-benzodioxin-6-yl)urea

G756-2320 Screening compound: 1-[3-({7-chloro-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl}methoxy)phenyl]-3-(2,3-dihydro-1,4-benzodioxin-6-yl)urea
G756-2320 Screening compound: 1-[3-({7-chloro-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl}methoxy)phenyl]-3-(2,3-dihydro-1,4-benzodioxin-6-yl)urea alternative view

Chemical Structure Depiction of ChemDiv screening compound G756-2320
1-[3-({7-chloro-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl}methoxy)phenyl]-3-(2,3-dihydro-1,4-benzodioxin-6-yl)urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G756-2320

Molecular Formula

C24H19ClN4O5 (C24 H19 ClN4 O5)

Compound Name

1-[3-({7-chloro-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl}methoxy)phenyl]-3-(2,3-dihydro-1,4-benzodioxin-6-yl)urea

IUPAC name

1-[3-({7-chloro-4-oxo-4H-pyrido[12-a]pyrimidin-2-yl}methoxy)phenyl]-3-(23-dihydro-14-benzodioxin-6-yl)urea

SMILES

O=C(Nc1cccc(OCC(N=C(C=C2)N3C=C2Cl)=CC3=O)c1)Nc(cc1)cc2c1OCCO2

InChI

InChI=1S/C24H19ClN4O5/c25-15-4-7-22-26-18(12-23(30)29(22)13-15)14-34-19-3-1-2-16(10-19)27-24(31)28-17-5-6-20-21(11-17)33-9-8-32-20/h1-7,10-13H,8-9,14H2,(H2,27,28,31)

InChI Key

BBJMZOCOSRYBIO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15033202

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

478.89

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.689

Distribution Coefficient, logD

2.689

Water Solubility, LogSw

-3.58

Polar Surface Area

82.098

Acid Dissociation Constant (pKa)

12.63

Base Dissociation Constant (pKb)

1.87

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.50

G756-2320 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with G756-2320 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G756-2320?
Check Price and Availability of G756-2320, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G756-2320 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G756-2320
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G756-2320
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G756-2320 available by request